Patents by Inventor Fred Vinick

Fred Vinick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of TNF-Alpha Signaling
    Publication number: 20130310388
    Abstract: The present invention provides compounds which are modulators of TNF-? signaling and methods of use thereof for treating a patient having a TNF-? mediated condition.
    Type: Application
    Filed: July 19, 2013
    Publication date: November 21, 2013
    Applicant: Genzyme Corporation
    Inventors: Scott F. Sneddon, John L. Kane, JR., Bradford H. Hirth, Fred Vinick, Shuang Qiao, Sharon R. Nahill, John M. Williams, Hans-Peter Biemann
  • Modulators of TNF-?signaling
    Patent number: 8518999
    Abstract: The present invention provides compounds which are modulators of TNF-? signaling and methods of use thereof for treating a patient having a TNF-? mediated condition.
    Type: Grant
    Filed: December 1, 2005
    Date of Patent: August 27, 2013
    Assignee: Genzyme Corporation
    Inventors: Scott F. Sneddon, John L. Kane, Bradford H. Hirth, Fred Vinick, Shuang Qiao, Sharon R. Nahill, John M. Williams, Hans-Peter Biemann
  • Modulators of TNF-alpha signaling
    Publication number: 20060173010
    Abstract: The present invention provides compounds which are modulators of TNF-? signaling and methods of use thereof for treating a patient having a TNF-? mediated condition.
    Type: Application
    Filed: December 1, 2005
    Publication date: August 3, 2006
    Inventors: Scott Sneddon, John Kane, Bradford Hirth, Fred Vinick, Shuang Qiao, Sharon Nahill, John Williams, Hans-Peter Biemann
  • Modulators of TNF-? signaling
    Patent number: 7034031
    Abstract: The present invention provides compounds which are modulators of TNF-? signaling and methods of use thereof for treating a patient having a TNF-? mediated condition.
    Type: Grant
    Filed: March 10, 2004
    Date of Patent: April 25, 2006
    Assignee: Genzyme Corporation
    Inventors: Scott F. Sneddon, John L. Kane, Bradford H. Hirth, Fred Vinick, Shuang Qiao, Sharon R. Nahill, John M. Williams, Hans-Peter Biemann
  • Modulators of TNF-? signaling
    Patent number: 6969728
    Abstract: The present invention provides compounds which are modulators of TNF-? signaling and methods of use thereof for treating a patient having a TNF-? mediated condition.
    Type: Grant
    Filed: May 10, 2001
    Date of Patent: November 29, 2005
    Assignee: Genzyme Corporation
    Inventors: Scott F. Sneddon, John L. Kane, Bradford H. Hirth, Fred Vinick, Shuang Qiao, Sharon R. Nahill, John M. Williams, Hans-Peter Biemann
  • Modulators of TNF-alfa signaling
    Publication number: 20040171617
    Abstract: The present invention provides compounds which are modulators of TNF-&agr; signaling and methods of use thereof for treating a patient having a TNF-&agr; mediated condition.
    Type: Application
    Filed: March 10, 2004
    Publication date: September 2, 2004
    Applicant: Genzyme Corporation
    Inventors: Scott F. Sneddon, John L. Kane, Bradford H. Hirth, Fred Vinick, Shuang Qiao, Sharon R. Nahill, John M. Williams, Hans-Peter Biemann
  • Modulators of TNF-alpha signaling
    Publication number: 20020119988
    Abstract: The present invention provides compounds which are modulators of TNF-&agr; signaling and methods of use thereof for treating a patient having a TNF-&agr; mediated condition.
    Type: Application
    Filed: May 10, 2001
    Publication date: August 29, 2002
    Applicant: Genzyme Corporation
    Inventors: Scott F. Sneddon, John L. Kane, Bradford H. Hirth, Fred Vinick, Shuang Qiao, Sharon R. Nahill
  • Antibacterial compounds
    Patent number: 6410533
    Abstract: The present invention provides compounds having useful antibacterial activity and pharmaceutical compositions comprising one or more of these compounds. The invention further relates to a method of treating a bacterial infection in a patient, comprising administering to the patient an effective mount of one or more of the antibacterial compounds of the invention.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: June 25, 2002
    Assignee: Genzyme Corporation
    Inventors: Bradford H. Hirth, Andrew Janjigian, Fred Vinick